SpringerLink
Log in

Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis

  • Chapter
  • First Online:
Tuberculosis

Part of the book series: Integrated Science ((IS,volume 11))

Summary

As children develop paucibacillary forms of tuberculosis (TB), bacteriological tests usually are negative. This chapter describes aspects of the laboratory tests available for clinical practice. It also discusses perspectives, such as biomarkers, which can be utilized in rapid tests, point of care (POC) tests, performed on samples other than sputum.

Graphical Abstract

Pediatric tuberculosis diagnosis

Many vague concepts on the pathogenesis of tuberculosis are attributable to an inadequate understanding of the basic facts and principles of the action of the bacteria and the reactions of the host.

Arnold Rich [1]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 160.49
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 213.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 213.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Rich A (1946) Patogenia de la tuberculosis. Buenos Aires, Alfa

    Google Scholar 

  2. World Health Organization (2019) Global tuberculosis report 2019. Available https://www.who.int/tb/publications/global_report/en/. Acessed 22 Jun 2020

  3. Sant’Anna CC, Schmidt CM, March MFBP, Pereira SM, Barreto ML (2013) Tuberculosis among adolescents in two Brazilian State capitals. Cad Saúde Pública 29(1):111–116

    Google Scholar 

  4. Carvalho ACC, Cardoso CAA, Martire TM, Migliori GB, Sant’Anna CC (2018) Aspectos epidemiológicos, manifestações clínicas e prevenção da tuberculose pediátrica sob a perspectiva da Estratégia End TB. J Bras Pneumol 44(2):134–144

    Article  PubMed  PubMed Central  Google Scholar 

  5. Gie R (2003) Diagnostic atlas of intrathoracic tuberculosis in children. International Union Against Tuberculosis and Lung Disease, Paris

    Google Scholar 

  6. Ministério da Saúde (2019) Manual de Recomendações para o Controle da Tuberculose no Brasil. Available http://bvsms.saude.gov.br/bvs/publicacoes/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf. Acessed 22 Jun 2020

  7. Nonyane BAS, Nicol MP, Andreas NJ, Rimmele S, Schneiderhan-Marra N, Workman LJ, Perkins MD, Joos T, Broger T, Ellner JJ, Alland D, Kampmann B, Dorman SE, Zar HJ (2018) Serologic responses in childhood pulmonary tuberculosis. Pediatr Infect Dis J 37(1):1–9

    Article  PubMed  PubMed Central  Google Scholar 

  8. Graham SM, Cuevas LE, Jean-Philippe P, Browning R, Casenghi RM, Detjen AK, Gnanashanmugam D, Hesseling AC, Kampmann B, Mandalakas A, Marais BJ, Schito M, Spiegel HML, Starke JR, Worrell C, Zar HJ (2015) Clinical case definitions for classification of intrathoracic tuberculosis in children: an update. Clin Infect Dis 61(Suppl 3):S179–S187

    Article  PubMed Central  Google Scholar 

  9. World Health Organization (2014) The End TB strategy global strategy and targets for tuberculosis prevention, care and control after 2015. Available https://www.who.int/tb/strategy/End_TB_Strategy.pdf?ua=1. Acessed 22 Jul 2020

  10. Lobue P, Menzies D (2010) Treatment of latent tuberculosis infection: an update. Respirology 15(4):603–622

    Google Scholar 

  11. World Health Organization (2017) Multidrug-resistant tuberculosis (MDR-TB) 2017 update. Available https://www.who.int/tb/challenges/mdr/MDR-RR_TB_factsheet_2017.pdf?ua=1. Acessed 22 Jul 2020

  12. World Health Organization (2020) WHO consolidated guidelines on tuberculosis module 3: diagnosis rapid diagnostics for tuberculosis detection. Available https://www.who.int/publications/i/item/who-consolidated-guidelines-on-tuberculosis-module-3-diagnosis---rapid-diagnostics-for-tuberculosis-detection. Acessed 22 Jul 2020

  13. Yerlikaya S, Broger T, MacLean E, Yerlikaya S, Broger T, MacLean E, Pai M, Denkinger CM (2017) A tuberculosis biomarker database: the key to novel TB diagnostics. Int J Infect Dis 56:253–257

    Article  CAS  PubMed  Google Scholar 

  14. Haas CT, Roe JK, Pollara G, Mehta M, Noursadeghi M (2016) Diagnostic ‘omics’ for active tuberculosis. BMC Med 14:37

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wessels G, Schaaf HS, Beyers N, Gie RP, Nel E, Donald PR (1999) Haematological abnormalities in children with tuberculosis. J Trop Pediatr 45(5):307–310

    Article  CAS  PubMed  Google Scholar 

  16. Abakay O, Abakay A, Sen HS, Tanrikulu AC (2015) The relationship between inflammatory marker levels and pulmonary tuberculosis severity. Inflammation 38(2):691–696

    Article  CAS  PubMed  Google Scholar 

  17. Peresi E, Silva SMR, Calvi SA, Marcondes-Machado J (2008) Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis. J Bras de Pneumol 34(11):942–949

    Article  Google Scholar 

  18. Martins C, Gama ACC, Valcarenghi D, Batschauer APB (2014) Markers of acute-phase response in the treatment of pulmonary tuberculosis. J Bras Patol Med Lab 50(6):428–433

    Article  CAS  Google Scholar 

  19. Nagu TJ, Spiegelman D, Hertzmark E, Aboud S, Makani J, Matee MI, Fawzi W, Mugusi F (2014) Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PLoSOne 18;9(3):e91229

    Google Scholar 

  20. Starke JR, Committee on Infectious Diseases (2014) Interferon-γ release assays for diagnosisoftuberculosisinfectionanddisease in children. Pediatrics 134(6):e1763–e1773

    Google Scholar 

  21. Gonzalez NE, Ferrero F (2015). Diagnóstico da Tuberculose na Infância. In: Tuberculose em crianças e jovens, 1st ed. Editora Atheneu, São Paulo, pp 17–24

    Google Scholar 

  22. Committee on Infectious Diseases, American Academy of Pediatrics (2018) Tuberculosis: 2018–2021 report of the committee on infectious diseases. 31th ed. Elk Grove Village IL pp 829–834

    Google Scholar 

  23. Starke JR (2012) Interferon-gama release assays for the diagnosis of tuberculosis Infection in children. J Pediatrics 161(4):581–582

    Article  Google Scholar 

  24. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y Hatherill M, Moyo S, Hanekom W, Mahomed H (2011) The utility of interferon-gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 30:694–700

    Google Scholar 

  25. World Health Organization (2015) Implementing tuberculosis diagnostic. Policy framework. Available https://apps.who.int/iris/bitstream/handle/10665/162712/9789241508612_eng.pdf;jsessionid=C5ACAB489566CAFC4731CEF90864F9A4?sequence=1. Acessed 01 Aug 2020

  26. Schaaf HS, Reuter H (2009) Practical approaches to ordering diagnostic tests. In: Schaaf HS, Zumla A (eds) Tuberculosis: a comprehensive clinical reference. Saunders, Elsevier, pp 216–226

    Google Scholar 

  27. Martire TM (2009) Diagnóstico laboratorial da tuberculose na infância: métodos convencionais e métodos rápidos. Pulmão RJ Supl 1:20-S27

    Google Scholar 

  28. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C (2004) Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 42:2321–2325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Nicol MP, Zar HJ (2011) New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev 12:16–21

    Article  PubMed  Google Scholar 

  30. Canetti G, Rist N, Grosset J (1963) Mesure de sensibilité du bacille tuberculeux aux drogues antibacillaire par la methode de proportions: methodologie, criterie de rèsitance, resultats et interpretations. Rev tub pneumol 27:217–272

    CAS  Google Scholar 

  31. Moore DA, Mendoza D, Gilman RH, Evans CAW, Delgado MGH, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, Soto G, Serpa J, Tuberculosis Working Group in Peru (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 42(10):4432–4437

    Google Scholar 

  32. Ha DT, Lan NT, Wolbers M, Duong TN, Quang ND, Thi Van Thinh T, Thi Hong Ngoc L, Thi Ngoc Anh N, Van Quyet T, Thi Bich Tuyen N, Thi Ha V, Day J, Thi Thanh Hang H, Kiet VS, Thi Nho N, Hoa DV, Dung NH, Huu Lan N, Farrar J, Caws M (2009) Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS ONE 4:e8341

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ministério da Saúde (2011) Manual de Recomendações para o Controle da Tuberculose no Brasil. Available http://bvsms.saude.gov.br/bvs/publicacoes/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf. Acessed 22 Jun 2020

  34. Nicol M, Whitelaw A, Stevens W (2013) Using Xpert M. TB/RIF. Curr Respir Med Rev 9(3):187–192

    Article  Google Scholar 

  35. Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR Jr (2019) Management of drug-resistant tuberculosis. The Lancet 394(10202):953–966

    Article  CAS  Google Scholar 

  36. Ministério da Saúde (2016) Teste rápido molecular para tuberculose.Nova tecnologia para o diagnóstico da tuberculose. http://www.saude.gov.br/images/pdf/2016/maio/18/folder-TRM-TB-grafica-reduzido.pdf. Acessed 30 Aug 2020

  37. Chakravorty S, Simmons AM, Rowneki M, Parmar H, Yuan Cao Y, Ryan J, Banada PP, Srinidhi Deshpande S, Shubhada Shenai S, Alexander Gall A, Glass , Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Allanda D (2017) The new xpert M. TB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-caretesting. mBio 29;8(4):e00812–e00817

    Google Scholar 

  38. World Health Organization (2017) Meeting report of a technical expert consultation: non-inferiority analysis of Xpert M. TB/RIF ultra compared toXpert M. TB/RIF. 11 p. Available https://www.who.int/tb/publications/2017/XpertUltra/en/. Acessed 01 Jul 2020

  39. Sieiro TA, Aurilio RB, Soares ECC, Chiang SS, Sant`Anna CC (2018) The role of the Xpert M. TB/RIF assay among adolescents suspected of pulmonary tuberculosis in Rio de Janeiro, Brazil. Rev Soc Bras Med Trop 51(2):234–236

    Google Scholar 

  40. Atherton RR, Cresswell FV, Ellis J, Kitaka SB, Boulware DR (2019) Xpert M. TB/RIF Ultra for tuberculosis testing in children: a mini-review and commentary. Front Pediatr 7:34

    Google Scholar 

  41. Detjen AK, DiNardo AR, Leyden J, Steingart KR, Menzies D, Schiller I, Dendukuri N, Mandalakas AM (2015) Xpert M. TB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. The Lancet Resp Med 3(6):451–61

    Google Scholar 

  42. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N (2014) Xpert® M. TB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review). Cochrane Database Of Systematic Reviews. Available https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470349/pdf/CD009593.pdf. Acessed 10 May 2020

  43. Ioos V, Cordel H, Bonnet M (2018) Alternative sputum collection methods for diagnosis of childhood intrathoracic tuberculosis: a systematic literature review. Arch Dis Child 104(7):629–635

    Google Scholar 

  44. Walters E, Goussard P, Bosch C, Hesseling AC, Gie RP (2013) GeneXpert M. TB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot study. Pediatr Pulmonol 55:1133–1137

    Google Scholar 

  45. Saini I, Mukherjee A, Gautam H, Singla M (2018) Diagnostic yield of Xpert M. TB/RIF in Bronchoalveolar lavage in children with probable pulmonary tuberculosis. Indian Pediatr 55(12):1062–1065

    Google Scholar 

  46. Bholla M, Kapalata N, Masika E, Chande H, Jugheli L, Sasamalo M, Glass TR, Peter Beck H-P, Reither K (2016) Evaluation of Xpert® M. TB/RIF and Ustar Easy NAT™ TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive study. BMC Infect Dis 16(1):1–9. Springer Science and Business Media LLC

    Google Scholar 

  47. Aruna J, Ratageri VH, Illalu S, Fattepur SR, Wari PK (2019) The utility of CSF xpert M. TB/RIF in diagnosis of tubercular meningitis in children. Indian J Pediatr 86(12):1089–1093

    Google Scholar 

  48. Lopez AL, Aldaba JG, Morales-Dizon M, Sarol JN, Daag JV, Ama MC, Sylim P, Salonga A, Nielsen-Saines K (2019) Urine Xpert M. TB/RIF for the diagnosis of childhood tuberculosis. Int J Infect Dis 79:44–46

    Article  CAS  PubMed  Google Scholar 

  49. Maynard-Smith L, Larke N, Peters JA, Lawn SD (2014) Diagnostic accuracy of the Xpert M. TB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis 14(1):1–15

    Google Scholar 

  50. Fantahun M, Kebede A, Yenew B, Gemechu T, Mamuye Y, Tadesse M, Brhane B, Jibriel A, Solomon D, Yaregal Z (2019) Diagnostic accuracy of Xpert M. TB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis. Shankar EM, PLoS ONE 14(9):e0222402

    Google Scholar 

  51. Nicol MP, Worman L, Prins M Bateman L, Ghebrekristos Y, Mbhele S, Denkinger CM, Zar HJ (2018) Accuracy of xpert M. tb/Rif ultra for the diagnosis of pulmonary tuberculosis in children. Pediatr Infect Dis J. 37(10):e261–e263

    Google Scholar 

  52. MacLean E, Kohli M, Weber SF, Suresh A, Schumacher SG, Denkinger CM, Pai M (2020) Advances in molecular diagnosis of TB. J Clin Microbiol. Accepted Manuscript posted on line

    Google Scholar 

  53. Singh S, Singh A, Prajapati S, Kabra SK, Lodha R, Mukherjee A, Singh V, Hesseling AC, Grewal HM (2015) Xpert M. TB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. BMC Microbiol 15(1):191

    Google Scholar 

  54. Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, Allen V, Boehme CC, Zemanay W, Nicol MP (2012) Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 55(8):1088–1095

    Article  PubMed  PubMed Central  Google Scholar 

  55. Zar HJ, Workman LJ, Prins M, Bateman LJ, Mbhele SP, Whitman CB, Denkinger CM, Nicol MP (2019) Tuberculosis diagnosis in children using xpert ultra on different respiratory specimens. Am J Respir Crit Care Med 200(12):1531–1538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Kabir S, Rahman SMM, Ahmed S, Islam MS, Banu RS, Shewade HD, Thekkur P, Anwar S, Banu NA, Nasrin R, Uddin MKM, Choudhury S, Ahmed S, Paul KK, Khatun R, Chisti MJ, Banu S (2020) Xpert ultra assay on stool to diagnose pulmonary tuberculosis in children. Clin Infect Dis. May 18; ciaa583

    Google Scholar 

  57. Doherty TM, Wallis RS, Zumla A Biomarkers of disease activity, cure, and relapse in tuberculosis (2009). Clin Chest Med 30(4):783–96

    Google Scholar 

  58. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95

    Article  Google Scholar 

  59. Wallis RS, Wang C, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S (2010) Zumla A (2010) Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 10(2):68–69. https://doi.org/10.1016/S1473-3099(10)70003-7

    Article  PubMed  Google Scholar 

  60. Loots DT (2016) TB or not TB? Improving the understanding and diagnosis of tuberculosis through metabolomics. Biomark Med 10(10):1025–1028

    Article  CAS  PubMed  Google Scholar 

  61. Goodridge A, Cueva C, Lahiff M, Muzanye G, Johnson JL, Nahid P, Riley LW (2012) Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response. Tuberculosis 92:243–247

    Article  CAS  PubMed  Google Scholar 

  62. Takenami I, de Oliveira CC, Lima FR, Soares J, Machado A Jr, Riley LW, Arruda S (2016) Immunoglobulin G response to mammalian cell entry 1A (Mce1A) protein as biomarker of active tuberculosis. Tuberculosis 100:82–88

    Article  CAS  PubMed  Google Scholar 

  63. Clavijo E, Díaz R, Anguita A, García A, Pinedo A, Smits HL (2003) Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis. Clin Diagn Lab Immunol 10:612–615

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Achkar JM, Ziegenbalg A (2012) Antibody responses to mycobacterial antigens in children with tuberculosis: challenges and potential diagnostic value. Clin Vaccine Immunol 19(12):1898–1906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Pan-Hammarström Q, Zhao Y, Hammarström L (2007) Class switch recombination: a comparison between mouse and human. Adv Immunol 93:1–61

    Article  PubMed  Google Scholar 

  66. Schroeder HW Jr, Mortari F, Shiokawa S, Kirkham PM, Elgavish RA (1995) Bertrand FE 3rd (1995) Developmental regulation of the human antibody repertoire. Ann NY Acad Sci 764:242–260

    Article  CAS  PubMed  Google Scholar 

  67. Schmidt CM, Lovero KL, Carvalho FR, Dos Santos DCM, Barros ACMW, Quintanilha AP, Barbosa AP, Pone MVS, Pone SM, Araujo JM, de Paula Martins C, Macedo SGD, Miceli AL, Vieira ML, Sias SMA, Queiroz A, Coca Velarde LG, Kritski AL, Silva AA, Sant'Anna CC, Riley LW, Araújo Cardoso CA (2020) Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents. Tuberculosis (Edinb) 120:101893

    Google Scholar 

  68. World Health Organization (2011) Tuberculosis serodiagnostic tests policy statement Available https://apps.who.int/iris/bitstream/handle/10665/44652/9789241502054_eng.pdf?sequence=1&isAllowed=y. Acessed 31 Aug 2020

  69. Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, Binder A, Meldau R, Hardy A, Dheda K (2012) Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 40:1211–1220

    Article  PubMed  PubMed Central  Google Scholar 

  70. Nicol MP, Allen V, Workman L, Isaacs W, Munro J, Pienaar S, Black F, Adonis L, Zemanay W, Ghebrekristos Y, Zar HJ (2014) Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study. Lancet Glob Health May 2(5):e278–84

    Google Scholar 

  71. Wei M, Wu ZY, Lin JH, Li Y, Qian ZX, **e YQ, Su H, Zhou W (2015) Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis. Genet Mol Res 14(4):17182–17192

    Article  CAS  PubMed  Google Scholar 

  72. Jenum S, Dhanasekaran S, Ritz C, Macaden R, Doherty TM, Grewal HM, Trials Study Group TB (2016) Added value of IP-10 as a read-out of mycobacterium tuberculosis: specific immunity in young children. Pediatr Infect Dis J 35(12):1336–1338

    Google Scholar 

  73. Sudbury EL, Otero L, Tebruegge M, Messina NL, Seas C, Montes M, Rìos J, Germano S, Gardiner K, Clifford V, Gotuzzo E, Curtis N (2019) Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting. J Clin Tuberc Other Mycobact Dis 16:100102

    Article  PubMed  PubMed Central  Google Scholar 

  74. Togun T, Hoggart CJ, Agbla SC, Gomez MP, Egere U, Sillah AK, Saidy B, Mendy F, Pai M, Kampmann B (2020) A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children. EBioMedicine 58:102909

    Article  PubMed  PubMed Central  Google Scholar 

  75. Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C, Merico D, Bader GD (2019) Pathway enrichment analysis and visualization of omics data using g:profiler. GSEA, Cytoscape and Enrichment Map Nat Protoc. 14(2):482–517

    Article  CAS  Google Scholar 

  76. Flores-Villalva S, Rogríguez-Hernández E, Rubio-Venegas Y, Cantó-Alarcón JG, Milián-Suazo F (2015) What can proteomics tell us about tuberculosis? J Microbiol Biotechnol. 25(8):1181–1194

    Google Scholar 

  77. Oliver SG (2002) Functional genomics: lessons from yeast. Philos Trans R Soc Lond B Biol Sci 357(1417):17–23

    Google Scholar 

  78. National Human Genome Research Institute (NHGRI) (2017) Transcriptome Fact Sheet https://www.genome.gov/13014330/transcriptome-fact-sheet/. Acessed 30 Mar 2017

  79. Anderson ST, Kaforou M, Brent AJ, Wright VJ, Banwell CM, Chagaluka G, Crampin AC, Dockrell HM, French N, Hamilton MS, Hibberd ML, Kern F, Langford PR, Ling L, Mlotha R, Ottenhoff THM, Pienaar S, Pillay V, Scott JAG, Twahir H, Wilkinson RJ, Coin LJ, Heyderman RS, Levin M, Eley B (2014) Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 370(18):1712–1723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Penn-Nicholson A, Hraha T, Thompson EG, Sterling D, Mbandi SK, Wall KM, Fisher M, Suliman S, Shankar S, Hanekom WA, Janjic N, Hatherill M, Kaufmann SHE, Sutherland J, Walzl G, De Groote MA, Ochsner U, Zak DE, Scriba TJ; ACS and GC6–74 cohort study groups (2019) Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study. PLoS Med 16(4):e1002781

    Google Scholar 

  81. WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Fluminense Federal University, Marquês do Paraná, Avenue, 303, Downtown Niterói, Rio de Janeiro, Brazil

    Christiane Mello Schmidt, Claudete Aparecida Araújo Cardoso & Maria de Fátima Bazhuni Pombo Sant’ Anna

  2. Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), Niterói, Brazil

    Christiane Mello Schmidt

  3. Institute of Pediatric Care and Pediatrics Martagão Gesteira, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Rafaela Baroni Aurílio

  4. School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Maria de Fátima Bazhuni Pombo Sant’ Anna

  5. School of of Medicine, Rio de Janeiro Federal University, Rio de Janeiro, Brazil

    Clemax Couto Sant’Anna

Authors
  1. Christiane Mello Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudete Aparecida Araújo Cardoso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rafaela Baroni Aurílio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria de Fátima Bazhuni Pombo Sant’ Anna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Clemax Couto Sant’Anna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christiane Mello Schmidt .

Editor information

Editors and Affiliations

  1. Universal Scientific Education and Research Network (USERN), Stockholm, Sweden

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schmidt, C.M., Cardoso, C.A.A., Aurílio, R.B., de Fátima Bazhuni Pombo Sant’ Anna, M., Sant’Anna, C.C. (2023). Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis. In: Rezaei, N. (eds) Tuberculosis. Integrated Science, vol 11. Springer, Cham. https://doi.org/10.1007/978-3-031-15955-8_11

Download citation

Publish with us

Policies and ethics

Search

Navigation